Bevo | Jotup

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on:

Monday, November 7, 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Constant of the Cannabis Market Generates Need for Intoxication Detection Devices

Retrieved on:

Monday, November 7, 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Presently, the medical cannabis sector accounts for a majority of the market share, as progress is slowly being made in removing the stigmas associated with such products. Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry. While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward. In 2020, legal cannabis sales in the U.S were up 46% from 2019, reaching a new record of USD 17.5 Billion, according to cannabinoid market research firm BDSA. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), SNDL Inc. (NASDAQ: SNDL), Tilray Brands, Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
While medical cannabis still dominates that broad cannabis marketplace, the growing awareness and legalization efforts are expected to further propel the overall industry forward.
The Company's proprietary breath capture and laboratory-based marijuana detection equipment (as described below) will be used to collect and confirm THC in breath samples.
The Cannabix BCU can be used to collect time of stop breath samples immediately upon suspicion of cannabis use by a driver.

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on:

Tuesday, October 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
While cannabis legalization is expanding so does the need for better regulations.
Cannabix has participated in two testing day events held in two different US cities in June and July.
Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices

Retrieved on:

Tuesday, October 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Sales of Cannabis products are expected to continue to grow as more states and major markets ease accessibility. According to data published by MJBizDaily, the combined U.S. medical and recreational cannabis sales could reach USD 33 billion by the end of 2022, mainly driven by the opening of new adult-use markets. Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026. The data also indicates that both medical and adult-use markets posted strong growth in 2021, up an estimated 34% and 43%, respectively, over 2020 sales. The outlook for the adult-use segment of the U.S. cannabis market is even stronger in the years to come as various states with the potential for massive markets, such as New York, are in the process of working out the final details to launch programs that have been approved. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)

Key Points:

Overall, retail cannabis sales are projected to cross the USD 52 billion mark by 2026.
Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Tilray Brands, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NASDAQ: CGC), Cronos Group Inc. (NASDAQ: CRON), Aurora Cannabis Inc. (NASDAQ: ACB)
While cannabis legalization is expanding so does the need for better regulations.
Cannabix has participated in two testing day events held in two different US cities in June and July.
Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."

A Market Leader Expands With Innovative CBD Gummy Line

Retrieved on:

Thursday, September 15, 2022

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line. Desperate for a good night's rest, more consumers are turning to CBD and CBN gummies for their sleep issues, especially as natural wellness trends have increased since the pandemic. Various cannabinoid products are available from the well-known industry developer and manufacturer of organic cannabinoid products in the form of oils (for humans and animals) and herbal capsules. To meet the growing consumer demand, cannabis companies Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), HEXO Corp (TSX:HEXO) (NASDAQ:HEXO), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY), and Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) are also expanding their CBD products line.

Key Points:

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line.
"Penetrating the US$261 billion tobacco products market in Europe is one of our top priorities."
The business created by Hoist and Hempshire U.S. union is well-positioned to dominate the market for tobacco- and nicotine-free smoking alternatives.
On August 15, Martha Stewart CBD's line of CBD gummies unveiled a new flavour - Pumpkin Spice CBD Wellness Gummies.

A Market Leader Expands With Innovative CBD Gummy Line

Retrieved on:

Thursday, September 15, 2022

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line. Desperate for a good night's rest, more consumers are turning to CBD and CBN gummies for their sleep issues, especially as natural wellness trends have increased since the pandemic. Various cannabinoid products are available from the well-known industry developer and manufacturer of organic cannabinoid products in the form of oils (for humans and animals) and herbal capsules. To meet the growing consumer demand, cannabis companies Hempshire Group (TSXV:HMPG) (OTCPK:HMPSF), HEXO Corp (TSX:HEXO) (NASDAQ:HEXO), Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), Tilray Brands Inc (TSX:TLRY) (NASDAQ:TLRY), and Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) are also expanding their CBD products line.

Key Points:

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- NuLeaf Naturals, one of America's top pioneering cannabinoid companies, has launched a new CBD gummies line.
"Penetrating the US$261 billion tobacco products market in Europe is one of our top priorities."
The business created by Hoist and Hempshire U.S. union is well-positioned to dominate the market for tobacco- and nicotine-free smoking alternatives.
On August 15, Martha Stewart CBD's line of CBD gummies unveiled a new flavour - Pumpkin Spice CBD Wellness Gummies.

Zenabis Announces Closing of Disposition of Bevo Farms Ltd.

Retrieved on:

Thursday, March 11, 2021

Bevo

On December 31, 2020, Langley subscribed for shares in the capital of Bevo, resulting in Langley owning, as of and from December 31, 2020, approximately 99% of the issued and outstanding shares of Bevo.

Key Points:

On December 31, 2020, Langley subscribed for shares in the capital of Bevo, resulting in Langley owning, as of and from December 31, 2020, approximately 99% of the issued and outstanding shares of Bevo.
The closing today was the sale of the remaining approximately 1% of the issued and outstanding shares of Bevo owned by Zenabis.
The cash closing proceeds received by Zenabis upon the closing today was approximately $8.79 million.
In addition, following the closing of the sale of Bevo to Langley, the Company's outstanding consolidated financial indebtedness has been significantly reduced since, concurrently with the closing of the sale of Bevo, Zenabis has been unconditionally released from its prior guarantee of Bevo's obligations to Bank of Montreal ("BMO") under the Bevo credit facility with BMO.

Zenabis Secures New Independent Director

Retrieved on:

Tuesday, November 27, 2018

Bevo

VANCOUVER, Nov.27, 2018 /CNW/ - Bevo Agro Inc. (TSXV: BVO) ("Bevo") and Sun Pharm Investments Ltd. ("Sun Pharm") are pleased to announce that Daniel Burns, on completion of the Bevo-Sun Pharm Transaction, will be an independent director of Zenabis Global Inc. ("Zenabis").

Key Points:

VANCOUVER, Nov.27, 2018 /CNW/ - Bevo Agro Inc. (TSXV: BVO) ("Bevo") and Sun Pharm Investments Ltd. ("Sun Pharm") are pleased to announce that Daniel Burns, on completion of the Bevo-Sun Pharm Transaction, will be an independent director of Zenabis Global Inc. ("Zenabis").
"The addition of Daniel Burns to the Board of Directors of Zenabis will bring a strong and strategic perspective to Zenabis' leadership team," said Monty Sikka, President and Director and of Sun Pharm, and proposed director of Zenabis.
"I am pleased to be joining Zenabis at a defining point in the company's evolution," said Mr. Burns.
"The combination of talent and experience at Bevo and Sun Pharm provides Zenabis an unprecedented opportunity and positions Zenabis as a market leader."

CubicFarm Systems readies for expansion into cannabis sector as Bevo Agro Inc. prepares to become Zenabis Global

Retrieved on:

Tuesday, October 9, 2018

Bevo

Today, Bevo introduces CubicFarm Systems Corp. ("CubicFarms"), an innovative, agriculture technology business that was developed by the Bevo management team.

Key Points:

Today, Bevo introduces CubicFarm Systems Corp. ("CubicFarms"), an innovative, agriculture technology business that was developed by the Bevo management team.
This investment will be held by Zenabis Ventures, Zenabis' wholly-owned cannabis venture platform.
CubicFarms has been building and selling systems since 2016, with its systems shipped from a state-of-the-art manufacturing facility.
"We look forward to working in partnership to help CubicFarms expand into worldwide markets as Zenabis continues to meet the growing global demand for cannabis."